Corbus Pharmaceuticals Holdings (CRBP) Equity Ratio (2013 - 2025)

Corbus Pharmaceuticals Holdings' Equity Ratio history runs 13 years deep, the most recent figure standing at 0.88 for Q4 2025.

• In Q4 2025, Equity Ratio fell 4.02% year-over-year to 0.88; the TTM figure through Dec 2025 stood at 0.88 (down 4.02% YoY), while the FY2025 annual figure was 0.88, down 4.02% from the prior year.
• Equity Ratio was 0.88 for Q4 2025 at Corbus Pharmaceuticals Holdings, up from 0.84 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.92 in Q3 2024 to a low of 0.24 in Q4 2023.
• Historically, Equity Ratio has averaged 0.61 across 5 years, with a median of 0.65 in 2021.
• The sharpest annual moves came in 2023 and 2024: Equity Ratio slumped 149.09% in 2023, then soared 10560.75% in 2024.
• A 5-year view of Equity Ratio shows it stood at 0.64 in 2021, then decreased by 22.45% to 0.5 in 2022, then plunged by 149.09% to 0.24 in 2023, then soared by 474.11% to 0.91 in 2024, then retreated by 4.02% to 0.88 in 2025.
• The last three Equity Ratio figures came in at 0.88 (Q4 2025), 0.84 (Q3 2025), and 0.89 (Q2 2025), per Business Quant data.